COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY

COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY

Introduction. Neoadjuvant chemotherapy (nact) is a potential alternative to chemoradiation therapy (crt) for rectal cancer and may allow early prevention of distant metastasis.Objective: to study the safety and efficacy of nact for patients with rectal cancer without damage to the mesorectal fascia....

Full description

Bibliographic Details
Main Authors:	S. O. Kochkina, S. S. Gordeyev, K. S. Petrov, Z. Z. Mammedli
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2021-08-01
Series:	Сибирский онкологический журнал
Subjects:	rectal cancer neoadjuvant chemotherapy chemoradiation therapy prognostic factors toxicity overall survival disease-free survival
Online Access:	https://www.siboncoj.ru/jour/article/view/1861

Similar Items

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
by: Ke Nie, et al.
Published: (2022-06-01)

Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery
by: Yahang Liang, et al.
Published: (2024-03-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study
by: Yi‐min Han, et al.
Published: (2023-06-01)

Intensification of neoadjuvant therapy in patients with locally advanced rectal cancer
by: Z. Z. Mamedli, et al.
Published: (2021-11-01)

Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study
by: Marina Morais, et al.
Published: (2023-03-01)

Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
by: Balaji Shewalkar, et al.
Published: (2023-07-01)

Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial
by: Flavius Sandra-Petrescu, et al.
Published: (2018-04-01)

Targeted Treatment Trastuzumab is found to greatly Improve Long Term Survival of HER2 Breast Cancer Patients
by: Mamdouh Ramadan, et al.
Published: (2020-01-01)

Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
by: Yuhong Chen, et al.
Published: (2022-06-01)

Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer
by: Shing Fung Lee, et al.
Published: (2024-01-01)

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
by: Christian Galata, et al.
Published: (2018-08-01)

GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer
by: Tae Hyun Kim, et al.
Published: (2023-03-01)

The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancerCentral MessagePerspective
by: Lye-Yeng Wong, MD, et al.
Published: (2023-06-01)

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis
by: Yu-Hsuan Kuo, et al.
Published: (2022-12-01)

Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response
by: Jianguo Yang, et al.
Published: (2024-01-01)

Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064)
by: Felix J. Hüttner, et al.
Published: (2018-01-01)

BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy
by: Liu H, et al.
Published: (2020-10-01)

Clinical Characteristics and Survival of Patients with Rectal Cancer
by: Simin Hemati, et al.
Published: (2014-07-01)

Transanal endoscopic microsurgery in the treatment of patients with benign neoplasms and early rectal cancer
by: V. A. Avdeenko, et al.
Published: (2022-01-01)

Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI‐detected extramural venous invasion
by: Mo Chen, et al.
Published: (2023-11-01)

Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response
by: Tae Hoon Lee, et al.
Published: (2023-07-01)

Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metformin
by: Bruna Costa, et al.
Published: (2022-09-01)

Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
by: Chun-Kai Liao, et al.
Published: (2022-05-01)

Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy
by: Zhendong Shi, et al.
Published: (2024-07-01)

Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer
by: Victor Lopez-Lopez, et al.
Published: (2016-01-01)

Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis
by: Qi Ling, et al.
Published: (2023-12-01)

The influence of some clinical and morphological prognosis factors on the 5-year survival of patients with stage I cervical cancer
by: E. V. Makarova, et al.
Published: (2019-12-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
by: Tarun Kumar, et al.
Published: (2020-03-01)

Effect of number of dissected lymph nodes on prognosis of patients with stage II and III colorectal cancer
by: Reihane Mokarian Rajabi, et al.
Published: (2023-05-01)

An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate
by: Supparerk Laohawiriyakamol, et al.
Published: (2023-02-01)

Deciphering the Dilemma: Choosing the Optimal Total Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer
by: Erik Manriquez, et al.
Published: (2024-07-01)

Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?
by: Hilmi Yazici, et al.
Published: (2024-02-01)

ASSOCIATION OF NKT- AND ACTIVATED CD25<sup>+</sup> PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS
by: A. I. Chertkova, et al.
Published: (2020-12-01)

Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Machine Learning Approach
by: Seyyed Hossein Mousavie Anijdan, et al.
Published: (2024-12-01)

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER
by: S. R. Altybaev, et al.
Published: (2016-11-01)

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
by: Yanan Wu, et al.
Published: (2017-05-01)

Preoperative Short-Course Radiotherapy and Surgery versus Surgery Alone for Patients with Rectal Cancer: A Propensity Score-Matched Analysis at 18-Year Follow-Up
by: Radoslaw Pach, et al.
Published: (2021-06-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)